Merck begins phase 3 trial of MK-1084, Keytruda combo for first-line treatment of certain patients with Metastatic Non-Small Cell Lung Cancer Ruchika Sharma6 April 2024 10:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced it has initiated a Phase 3 clinical trial evaluating MK-1084,...
European Commission approves Merck Keytruda plus Chemotherapy for lung cancer Ruchika Sharma1 April 2024 5:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Commission (EC) has approved KEYTRUDA,...
Merck gets USFDA nod for WINREVAIR (sotatercept-csrk) for adults with pulmonary arterial hypertension Ruchika Sharma27 March 2024 11:51 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved...
Merck Speciality gets CDSCO Panel Nod To study anti-cancer drug Avelumab Dr. Divya Colin22 March 2024 5:45 PM ISTNew Delhi: The drug major Merck Speciality has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Merck plans to conduct clinical trials of Multi-Valent HPV vaccine, single-dose regimen for GARDASIL9 Susmita Roy14 March 2024 3:09 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, at the EUROGIN 2024 HPV Congress, has announced plans to initiate clinical...
Merck concludes acquisition of Harpoon Therapeutics Ruchika Sharma13 March 2024 12:59 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has completed the acquisition of Harpoon Therapeutics, Inc. Harpoon is now a...
Germany Merck sees return to organic earnings growth in 2024 Ruchika Sharma7 March 2024 4:52 PM ISTFrankfurt: Merck KGaA forecast a return to modest operating earnings growth this year but only when adjusted for currency headwinds, citing a...
Merck gets positive EMA Committee opinion for Keytruda, chemotherapy combo for Resectable non-small cell lung cancer Ruchika Sharma26 Feb 2024 2:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency's Committee for Medicinal...
Merck application for Keytruda plus chemotherapy for Primary Advanced or Recurrent Endometrial Carcinoma accepted by USFDA for priority review Ruchika Sharma22 Feb 2024 12:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
MSD NOT involved in Poonam Pandey fake death stunt: Makers of Gardasil clarify, cut ties with agency involved in controversy Farhat Nasim7 Feb 2024 4:50 PM ISTNew Delhi: MSD, the Indian affiliate of the US pharmaceutical giant Merck has clarified that it is not associated with actor and model Poonam Pandey’s...
Merck seeks more deals to prepare for Keytruda revenue decline Ruchika Sharma4 Feb 2024 12:30 PM ISTMerck & Co on Thursday said it was in the market for deals of up to around $15 billion as it plans for a loss of revenue from its aging cancer...
Merck gets USFDA nod for Keytruda plus chemoradiotherapy for FIGO 2014 Stage III-IVA Cervical Cancer Ruchika Sharma13 Jan 2024 1:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA,...
